Molina-Andújar, Alícia
Robles, Pau
Cibeira, Maria T.
Montagud-Marrahi, Enrique
Guillen, Elena
Xipell, Marc
Blasco, Miquel
Poch, Esteban
Rosiñol, Laura
Bladé, Joan
Quintana, Luis F.
Article History
Received: 4 January 2020
Accepted: 19 March 2020
First Online: 31 March 2020
Ethics approval
: The study was carried out in compliance with the Declaration of Helsinki (current version, Fortaleza, Brazil, October 2013) and in accordance with Law 14/2007 of July 3, on Biomedical Research. Informed consent was not requested from patients as it was a retrospective study. The study was approved by the ethic’s comittee of Hospital Clínic de Barcelona: CEIm (Comité de ética de la investigación).
: Not applicable.
: JB and LR declare honorary for lectures and advisory boards for Celgene, Janssen, Amgen and Takeda.MTC declares honorary for lectures for Janssen and Celgene and advisory board for Janssen.LFQ declares honorary for lectures for Celgene and Amgen.